Resources are here for you
There's a lot to know about bladder cancer and its treatment options. It might feel overwhelming at times, but we're here to help by sharing resources and information.
That begins with a few resources we've designed for you and the family or friends you choose to share them with.
Patient resources
Living with LG-IR-NMIBC may feel overwhelming at times. That's why we've created resources to support you. Download these tools to stay informed and take an active role in your care.
Patient
Doctor Discussion Guide
This discussion guide will help you ask your doctor important questions to learn more about ZUSDURI and understand if it may be right for you.
Patient
DownloadPatient
Patient Brochure
This guide includes information on ZUSDURI along with management tips, and provides a journal to help you stay on track with your treatment.
Patient
DownloadHelpful terms
Caregiver resources
As a caregiver, your role is vital in offering support throughout the journey. To help support you, we've gathered a few trusted resources from organizations dedicated to patients' and caregivers' education and well-being:
BCAN - Tips for Caregivers Handbook
CancerCare Resources for Caregivers
American Bladder Cancer Society - Caregiver Page & Community Forum
Julio is a ZUSDURI patient.*Advocacy and support groups
Several organizations offer support for patients and caregivers concerned about bladder cancer. Consider reaching out to them.
UroGen is not responsible for the content or activities of these organizations.
Bladder Cancer Advocacy Network
American Cancer Society
Cancer Support Community
Urology Care Foundation
CancerCare
Cancer Hope NetworkPatient support programs
We understand that navigating insurance coverage and treatment costs can feel overwhelming. For eligible patients, there may be a program that can help you with affordability, access, and to determine your insurance coverage. These programs are available through your doctor's office.
Insurance coverage determination
We will work with your doctor's office to check on what the insurance company will reimburse and what your copay may be.
Commercial copay program
You may qualify for the UroGen Support™ Copay Program. If you are eligible, you will pay as little as $50 for each dose with a maximum benefit of $14,000/year. Additional terms and conditions apply.
Independent charitable foundation support
If you have Medicare or Medicaid, charitable foundations may help pay for your treatment. Ask your doctor about which foundations are available.
Patient assistance program
If you don't have insurance, you may qualify for the UroGen Support™ Patient Assistance Program. If you qualify, this program will cover the cost of ZUSDURI.
Talk to your doctor about which program is right for you
*Compensated for their time.
Stay up-to-date on new resources
Sign UpAPPROVED USE FOR ZUSDURI
ZUSDURI (mitomycin) for intravesical solution is a prescription medicine used to treat adults with a type of cancer of the lining of the bladder called low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) after you have previously received bladder surgery to remove tumor and it did not work or is no longer working.
IMPORTANT SAFETY INFORMATION
You should not receive ZUSDURI if you have a hole or tear (perforation) of your bladder or if you have had an allergic reaction to mitomycin or to any of the ingredients in ZUSDURI.
Before receiving ZUSDURI, tell your healthcare provider about all of your medical conditions, including if you:
- have kidney problems
- are pregnant or plan to become pregnant. ZUSDURI can harm your unborn baby. You should not become pregnant during treatment with ZUSDURI. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with ZUSDURI.
- Females who are able to become pregnant: You should use effective birth control (contraception) during treatment with ZUSDURI and for 6 months after the last dose.
- Males being treated with ZUSDURI: You should use effective birth control (contraception) during treatment with ZUSDURI and for 3 months after the last dose.
- are breastfeeding or plan to breastfeed. It is not known if ZUSDURI passes into your breast milk. Do not breastfeed during treatment with ZUSDURI and for 1 week after the last dose.
How will I receive ZUSDURI?
- You will receive your ZUSDURI dose from your healthcare provider 1 time a week for 6 weeks into your bladder through a tube called a urinary catheter. It is important that you receive all 6 doses of ZUSDURI according to your healthcare provider’s instructions.
- If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment.
- During treatment with ZUSDURI, your healthcare provider may tell you to take additional medicines or change how you take your current medicines.
After receiving ZUSDURI:
- ZUSDURI may cause your urine color to change to a violet to blue color. Avoid contact between your skin and urine for at least 24 hours.
- To urinate, males and females should sit on a toilet and flush the toilet several times after you use it. After going to the bathroom, wash your hands, your inner thighs, and genital area well with soap and water.
- Clothing that comes in contact with urine should be washed right away and washed separately from other clothing.
The most common side effects of ZUSDURI include: increased blood creatinine levels, increased blood potassium levels, trouble with urination, decreased red blood cell counts, increase in certain blood liver tests, increased or decreased white blood cell counts, urinary tract infection, blood in your urine.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to UroGen Pharma at 1-855-987-6436.
Please see ZUSDURI Full Prescribing Information, including the Patient Information, for additional information.
ZUSDURI™ and UroGen Support™ are trademarks and UroGen® is a registered trademark of UroGen Pharma, Ltd. All other trademarks are the property of their respective owners.
©2025 UroGen Pharma, Inc. All rights reserved. US-ZUS-00046 06/25
This site is intended for US patients and caregivers.